$CPIX
CUMBERLAND PHARMACEUTICALS INC

2020 Q4 Form 10-Q Financial Statement

#000162828020016446 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $10.26M $9.251M $9.306M
YoY Change 10.27% 33.38% -11.27%
Cost Of Revenue $2.070M $2.143M $2.390M
YoY Change -13.39% 35.57% 58.28%
Gross Profit $8.200M $7.108M $6.920M
YoY Change 18.5% 32.74% 1053.33%
Gross Profit Margin 79.91% 76.84% 74.36%
Selling, General & Admin $7.190M $5.969M $7.180M
YoY Change 0.14% 2.13% 150.17%
% of Gross Profit 87.68% 83.98% 103.76%
Research & Development $1.400M $1.230M $2.080M
YoY Change -32.69% -26.45% -29.25%
% of Gross Profit 17.07% 17.31% 30.06%
Depreciation & Amortization $1.230M $1.190M $1.120M
YoY Change 9.82% 7.21% 28.74%
% of Gross Profit 15.0% 16.74% 16.18%
Operating Expenses $9.740M $7.199M $10.31M
YoY Change -5.53% -4.23% 55.27%
Operating Profit -$1.746M -$1.209M -$3.394M
YoY Change -48.56% -62.19% 3.07%
Interest Expense -$30.00K $75.21K $20.00K
YoY Change -250.0% 15.93% -33.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.780M -$1.272M -$3.380M
YoY Change -47.34% -61.6% -43.85%
Income Tax $10.00K $3.728K -$10.00K
% Of Pretax Income
Net Earnings -$883.8K -$481.7K -$960.7K
YoY Change -8.01% -75.34% -56.73%
Net Earnings / Revenue -8.61% -5.21% -10.32%
Basic Earnings Per Share -$0.06 -$0.03 -$0.06
Diluted Earnings Per Share -$0.06 -$0.03 -$0.06
COMMON SHARES
Basic Shares Outstanding 15.04M shares 15.13M shares 15.18M shares
Diluted Shares Outstanding 15.13M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.80M $26.60M $28.20M
YoY Change -12.06% -9.04% -22.16%
Cash & Equivalents $24.75M $26.65M $28.21M
Short-Term Investments $0.00
Other Short-Term Assets $2.200M $1.778M $2.757M
YoY Change -20.22% -10.76% -6.96%
Inventory $10.64M $10.08M $8.871M
Prepaid Expenses
Receivables $12.38M $9.661M $7.859M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $49.97M $48.89M $50.16M
YoY Change -0.39% -1.02% -15.14%
LONG-TERM ASSETS
Property, Plant & Equipment $574.2K $602.9K $747.8K
YoY Change -23.22% -18.94% -3.04%
Goodwill $882.0K $882.0K $882.0K
YoY Change 0.0% 0.0% 12.5%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.234M $2.512M $3.299M
YoY Change -1.95% -60.31% 30.32%
Total Long-Term Assets $46.49M $47.12M $54.39M
YoY Change -14.51% -13.34% 1.51%
TOTAL ASSETS
Total Short-Term Assets $49.97M $48.89M $50.16M
Total Long-Term Assets $46.49M $47.12M $54.39M
Total Assets $96.46M $96.01M $104.5M
YoY Change -7.73% -7.47% -7.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.40M $10.83M $9.994M
YoY Change 34.05% 31.69% 21.71%
Accrued Expenses $11.25M $1.000M $11.08M
YoY Change 1.53% 11.11% -30.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.000M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.67M $23.94M $24.15M
YoY Change 6.28% 13.7% -13.14%
LONG-TERM LIABILITIES
Long-Term Debt $15.00M $15.00M $18.50M
YoY Change -18.92% -25.0% -7.5%
Other Long-Term Liabilities $7.863M $9.200M $8.737M
YoY Change -10.01% -16.36% -6.24%
Total Long-Term Liabilities $7.863M $24.20M $8.737M
YoY Change -10.01% -21.94% -6.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.67M $23.94M $24.15M
Total Long-Term Liabilities $7.863M $24.20M $8.737M
Total Liabilities $49.59M $48.17M $53.46M
YoY Change -7.25% -7.48% -6.41%
SHAREHOLDERS EQUITY
Retained Earnings -$2.131M -$1.247M $1.208M
YoY Change -276.35% -157.5% -74.54%
Common Stock $49.12M $49.18M $49.91M
YoY Change -1.59% -0.78% -2.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $46.99M $47.93M $51.12M
YoY Change
Total Liabilities & Shareholders Equity $96.46M $96.01M $104.5M
YoY Change -7.73% -7.47% -7.23%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income -$883.8K -$481.7K -$960.7K
YoY Change -8.01% -75.34% -56.73%
Depreciation, Depletion And Amortization $1.230M $1.190M $1.120M
YoY Change 9.82% 7.21% 28.74%
Cash From Operating Activities $860.0K $860.0K $860.0K
YoY Change 0.0% 16.22% -76.88%
INVESTING ACTIVITIES
Capital Expenditures -$210.0K -$1.130M -$360.0K
YoY Change -41.67% 527.78% -86.67%
Acquisitions
YoY Change
Other Investing Activities -$100.0K $460.0K $2.260M
YoY Change -104.42% -93.54% -112.07%
Cash From Investing Activities -$320.0K -$670.0K $1.910M
YoY Change -116.75% -109.65% -108.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.430M -920.0K -1.530M
YoY Change 58.82% -43.9% -120.76%
NET CHANGE
Cash From Operating Activities 860.0K 860.0K 860.0K
Cash From Investing Activities -320.0K -670.0K 1.910M
Cash From Financing Activities -2.430M -920.0K -1.530M
Net Change In Cash -1.890M -730.0K 1.240M
YoY Change -252.42% -112.09% -112.02%
FREE CASH FLOW
Cash From Operating Activities $860.0K $860.0K $860.0K
Capital Expenditures -$210.0K -$1.130M -$360.0K
Free Cash Flow $1.070M $1.990M $1.220M
YoY Change -12.3% 116.3% -81.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001087294
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33637
dei Entity Registrant Name
EntityRegistrantName
Cumberland Pharmaceuticals Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1765329
dei Entity Address Address Line1
EntityAddressAddressLine1
2525 West End Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 950
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37203
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
255-0068
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock, no par value
dei Trading Symbol
TradingSymbol
CPIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15036923 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26646530 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28212635 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9661407 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7843917 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
10080394 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
8871254 USD
CY2020Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
727670 USD
CY2019Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
2477813 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1778078 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2757456 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
48894079 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
50163075 USD
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
12649184 USD
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
15554992 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
602911 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
747796 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28180090 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30920324 USD
CY2020Q3 us-gaap Goodwill
Goodwill
882000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
882000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21802 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21802 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2267669 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2960569 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2511894 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3298725 USD
CY2020Q3 us-gaap Assets
Assets
96009629 USD
CY2019Q4 us-gaap Assets
Assets
104549283 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10833972 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9993578 USD
CY2020Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2019Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1918868 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
991969 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
920431 USD
CY2020Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10112100 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11317358 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
23938041 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24150235 USD
CY2020Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000 USD
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
18500000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1323792 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2076472 USD
CY2020Q3 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
7904419 USD
CY2019Q4 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
8737323 USD
CY2020Q3 us-gaap Liabilities
Liabilities
48166252 USD
CY2019Q4 us-gaap Liabilities
Liabilities
53464030 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15084372 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15084372 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15263355 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15263355 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
49176040 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
49914478 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1247237 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1208395 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
47928803 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
51122873 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
-85426 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
-37620 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47843377 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51085253 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96009629 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104549283 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9250689 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6935439 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27179600 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25082742 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2142839 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1580650 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6387002 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5031732 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3587842 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3812467 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11160924 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11231778 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1230335 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1672843 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4374392 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4788698 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2381273 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2032129 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6608322 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6839187 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1117086 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1033786 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3284610 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3085139 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
10459375 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
10131875 USD
us-gaap Costs And Expenses
CostsAndExpenses
31815250 USD
us-gaap Costs And Expenses
CostsAndExpenses
30976534 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1208686 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3196436 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4635650 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5893792 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
12004 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
-50511 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
70553 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
195915 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
75210 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
64877 USD
us-gaap Interest Expense
InterestExpense
227730 USD
us-gaap Interest Expense
InterestExpense
216988 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1271892 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3311824 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4792827 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5914865 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3728 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4462 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45423 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-72504 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1275620 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3316286 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4838250 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5842361 USD
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
777916 USD
CY2019Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1349351 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2334811 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
3268196 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-497704 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1966935 USD
us-gaap Profit Loss
ProfitLoss
-2503439 USD
us-gaap Profit Loss
ProfitLoss
-2574165 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-15967 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13267 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-47806 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2888 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-481737 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1953668 USD
us-gaap Net Income Loss
NetIncomeLoss
-2455633 USD
us-gaap Net Income Loss
NetIncomeLoss
-2577053 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.31
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.38
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
CY2019Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.09
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.15
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.21
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.31
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.38
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.05
CY2019Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.09
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.15
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.21
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15134583 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15368027 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15206179 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15454159 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15134583 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15368027 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15206179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15454159 shares
us-gaap Profit Loss
ProfitLoss
-2574165 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2334811 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
3268196 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5842361 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3524684 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3278958 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43605 USD
us-gaap Share Based Compensation
ShareBasedCompensation
805338 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1107817 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
806390 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
681577 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36197 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36292 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
34303 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1817490 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1026633 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1696668 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1332140 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1962024 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-195529 USD
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
3417856 USD
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
-539525 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1585584 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-207648 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2395054 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-284440 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
2166086 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
2483796 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4561140 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2199356 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95189 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
166407 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9627191 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15686334 USD
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
460888 USD
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
5000000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1807467 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
498003 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1441768 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
394733 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
44000000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
56000000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
45500000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
56000000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
52500 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
834014 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
908347 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
800000 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1551463 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2593778 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4685477 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3554625 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1566105 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-960536 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28212635 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27938960 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26646530 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26978424 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55570501 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
364434 USD
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
703790 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-40418 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55190727 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55190727 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
396548 USD
CY2019Q2 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
800000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
531746 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-566812 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
53688717 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
53688717 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
346835 USD
CY2019Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-1000000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1361689 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1966935 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51706928 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51085253 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
264574 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
441624 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-1065145 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49843058 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49843058 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
278349 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
769648 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-940589 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48411170 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48411170 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
262415 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
332504 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-497704 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47843377 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns (2) the allowances for obsolescent or unmarketable inventory (3) assumptions used in estimating acquisition date fair value of assets acquired in business combinations and (4) valuation of contingent consideration liability associated with business combinations.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2315761 USD
CY2020Q3 us-gaap Trading Securities
TradingSecurities
0 USD
CY2019Q4 us-gaap Trading Securities
TradingSecurities
2119607 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1275620 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3316286 USD
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
777916 USD
CY2019Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1349351 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-15967 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13267 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-481737 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1953668 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15134583 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15368027 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3600 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15134583 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15368027 shares
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4838250 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5842361 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2334811 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
3268196 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-47806 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2888 USD
us-gaap Net Income Loss
NetIncomeLoss
-2455633 USD
us-gaap Net Income Loss
NetIncomeLoss
-2577053 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15206179 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15454159 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15206179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15454159 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
197210 shares
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19345723 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9250689 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6935439 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27179600 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25082742 USD
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
12600000 USD
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
15600000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17064269 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19345723 USD
CY2020Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
250615 USD
CY2019Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
416468 USD
CY2019Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
416468 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5414694 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4664055 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4664055 USD
CY2020Q3 us-gaap Inventory Gross
InventoryGross
22729578 USD
CY2019Q4 us-gaap Inventory Gross
InventoryGross
24426246 USD
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
12649184 USD
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
15554992 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
10080394 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
8871254 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0742
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2267669 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2960569 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
991969 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
920431 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1323792 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2076472 USD
CY2020Q3 cpix Lease Liability
LeaseLiability
2315761 USD
CY2019Q4 cpix Lease Liability
LeaseLiability
2996903 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
288781 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1144889 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1019313 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
92478 USD
CY2020Q3 cpix Lessee Operating Lease Liability To Be Paid After Year Three
LesseeOperatingLeaseLiabilityToBePaidAfterYearThree
0 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2545461 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
229700 USD
CY2010Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2016Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
10080 shares
CY2017Q4 cpix Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities
StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
100000000 USD
CY2019Q2 cpix Subsidiary Investment Cash Contribution
SubsidiaryInvestmentCashContribution
300000 USD
CY2019Q2 cpix Subsidiary Investment Conversion Of Intercompany Loans Payable
SubsidiaryInvestmentConversionOfIntercompanyLoansPayable
700000 USD
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
18500000 USD
CY2020Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000.0 USD
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
44100000 USD

Files In Submission

Name View Source Status
0001628280-20-016446-index-headers.html Edgar Link pending
0001628280-20-016446-index.html Edgar Link pending
0001628280-20-016446.txt Edgar Link pending
0001628280-20-016446-xbrl.zip Edgar Link pending
a2020q3-exhibit101.htm Edgar Link pending
a2020q3-exhibit311.htm Edgar Link pending
a2020q3-exhibit312.htm Edgar Link pending
a2020q3-exhibit321.htm Edgar Link pending
cpix-20200930.htm Edgar Link pending
cpix-20200930.xsd Edgar Link pending
cpix-20200930_cal.xml Edgar Link unprocessable
cpix-20200930_def.xml Edgar Link unprocessable
cpix-20200930_htm.xml Edgar Link completed
cpix-20200930_lab.xml Edgar Link unprocessable
cpix-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending